Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) During Therapy With Spiolto® Respimat® [ELLACTO]
收藏DataCite Commons2024-12-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007360/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Open-label observational study: including COPD patients receiving treatment with Spiolto®
Respimat® for approximately 6 weeks, which is the average time between two medical
consultations
提供机构：
Vivli
创建时间：
2021-08-25
